Label Changes for:
Dipentum (olsalazine sodium) 250 mg capsules
Changes have been made to the ADVERSE REACTIONS sections of the safety label.
Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) -- August 2009
- addition of new safety information